 | • レポートコード：MRC23Q36661 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（2-3日） • 産業分類：医薬品 |
| Single User | ￥429,200 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥858,400 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界のBCGワクチン市場について調査・分析し、世界のBCGワクチン市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（免疫、治療）、用途別セグメント分析（3ヶ月以下乳児、5IUPPD陰性子供）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Merck、Sanofi Pasteur、Japan BCG Lab、China National Biotec、Serum Institute of India、GSBPLなどが含まれています。世界のBCGワクチン市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、BCGワクチン市場規模を推定する際に考慮しました。本レポートは、BCGワクチンの世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、BCGワクチンに関するビジネス上の意思決定に役立てることを目的としています。 ・BCGワクチン市場の概要 - 製品の定義 - BCGワクチンのタイプ別セグメント - 世界のBCGワクチン市場規模：タイプ別分析（免疫、治療） - BCGワクチンの用途別セグメント - 世界のBCGワクチン市場規模：用途別分析（3ヶ月以下乳児、5IUPPD陰性子供） - 世界のBCGワクチン市場規模予測（2018年-2029年） - BCGワクチンの平均価格推移（2018年-2029年） - 前提条件と制限事項 ・メーカー別競争状況 - メーカー別市場シェア - 世界の主要メーカー、業界ランキング分析 - メーカー別平均価格 - BCGワクチン市場の競争状況およびトレンド ・BCGワクチンの地域別市場規模 - 北米のBCGワクチン市場規模（2018年-2029年） - アメリカのBCGワクチン市場規模（2018年-2029年） - ヨーロッパのBCGワクチン市場規模（2018年-2029年） - アジア太平洋のBCGワクチン市場規模（2018年-2029年） - 中国のBCGワクチン市場規模（2018年-2029年） - 日本のBCGワクチン市場規模（2018年-2029年） - 韓国のBCGワクチン市場規模（2018年-2029年） - インドのBCGワクチン市場規模（2018年-2029年） - オーストラリアのBCGワクチン市場規模（2018年-2029年） - 中南米のBCGワクチン市場規模（2018年-2029年） - 中東・アフリカのBCGワクチン市場規模（2018年-2029年） ・タイプ別セグメント：免疫、治療 - 世界のBCGワクチンのタイプ別販売量（2018年-2023年） - 世界のBCGワクチンのタイプ別売上（2018年-2023年） - 世界のBCGワクチンのタイプ別価格 ・用途別セグメント：3ヶ月以下乳児、5IUPPD陰性子供 - 世界のBCGワクチンの用途別販売量（2018年-2023年） - 世界のBCGワクチンの用途別売上（2018年-2023年） - 世界のBCGワクチンの用途別価格 ・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向 Merck、Sanofi Pasteur、Japan BCG Lab、China National Biotec、Serum Institute of India、GSBPL ・産業チェーンと販売チャネルの分析 - BCGワクチン産業チェーン分析 - BCGワクチンの主要原材料 - BCGワクチンの販売チャネル - BCGワクチンのディストリビューター - BCGワクチンの主要顧客 ・BCGワクチン市場ダイナミクス - BCGワクチンの業界動向 - BCGワクチン市場の成長ドライバ、課題、阻害要因 ・調査成果および結論 ・調査方法とデータソース |
Highlights
The global Bacille Calmette-Guérin Vaccine market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Bacille Calmette-Guérin Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Bacille Calmette-Guérin Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Bacille Calmette-Guérin Vaccine include Merck, Sanofi Pasteur, Japan BCG Lab, China National Biotec, Serum Institute of India and GSBPL, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Bacille Calmette-Guérin Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bacille Calmette-Guérin Vaccine.
The Bacille Calmette-Guérin Vaccine market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Bacille Calmette-Guérin Vaccine market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bacille Calmette-Guérin Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Merck
Sanofi Pasteur
Japan BCG Lab
China National Biotec
Serum Institute of India
GSBPL
Segment by Type
Immune Bacille Calmette-Guérin
Therapy Bacille Calmette-Guérin
Segment by Application
Infants Under 3 Months
Children Test Negative With 5IUPPD
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Bacille Calmette-Guérin Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Bacille Calmette-Guérin Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Bacille Calmette-Guérin Vaccine Market Overview
1.1 Product Overview and Scope of Bacille Calmette-Guérin Vaccine
1.2 Bacille Calmette-Guérin Vaccine Segment by Type
1.2.1 Global Bacille Calmette-Guérin Vaccine Market Value Comparison by Type (2023-2029)
1.2.2 Immune Bacille Calmette-Guérin
1.2.3 Therapy Bacille Calmette-Guérin
1.3 Bacille Calmette-Guérin Vaccine Segment by Application
1.3.1 Global Bacille Calmette-Guérin Vaccine Market Value by Application: (2023-2029)
1.3.2 Infants Under 3 Months
1.3.3 Children Test Negative With 5IUPPD
1.4 Global Bacille Calmette-Guérin Vaccine Market Size Estimates and Forecasts
1.4.1 Global Bacille Calmette-Guérin Vaccine Revenue 2018-2029
1.4.2 Global Bacille Calmette-Guérin Vaccine Sales 2018-2029
1.4.3 Global Bacille Calmette-Guérin Vaccine Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Bacille Calmette-Guérin Vaccine Market Competition by Manufacturers
2.1 Global Bacille Calmette-Guérin Vaccine Sales Market Share by Manufacturers (2018-2023)
2.2 Global Bacille Calmette-Guérin Vaccine Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Bacille Calmette-Guérin Vaccine Average Price by Manufacturers (2018-2023)
2.4 Global Bacille Calmette-Guérin Vaccine Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Bacille Calmette-Guérin Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Bacille Calmette-Guérin Vaccine, Product Type & Application
2.7 Bacille Calmette-Guérin Vaccine Market Competitive Situation and Trends
2.7.1 Bacille Calmette-Guérin Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Bacille Calmette-Guérin Vaccine Players Market Share by Revenue
2.7.3 Global Bacille Calmette-Guérin Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Bacille Calmette-Guérin Vaccine Retrospective Market Scenario by Region
3.1 Global Bacille Calmette-Guérin Vaccine Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Bacille Calmette-Guérin Vaccine Global Bacille Calmette-Guérin Vaccine Sales by Region: 2018-2029
3.2.1 Global Bacille Calmette-Guérin Vaccine Sales by Region: 2018-2023
3.2.2 Global Bacille Calmette-Guérin Vaccine Sales by Region: 2024-2029
3.3 Global Bacille Calmette-Guérin Vaccine Global Bacille Calmette-Guérin Vaccine Revenue by Region: 2018-2029
3.3.1 Global Bacille Calmette-Guérin Vaccine Revenue by Region: 2018-2023
3.3.2 Global Bacille Calmette-Guérin Vaccine Revenue by Region: 2024-2029
3.4 North America Bacille Calmette-Guérin Vaccine Market Facts & Figures by Country
3.4.1 North America Bacille Calmette-Guérin Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Bacille Calmette-Guérin Vaccine Sales by Country (2018-2029)
3.4.3 North America Bacille Calmette-Guérin Vaccine Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Bacille Calmette-Guérin Vaccine Market Facts & Figures by Country
3.5.1 Europe Bacille Calmette-Guérin Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Bacille Calmette-Guérin Vaccine Sales by Country (2018-2029)
3.5.3 Europe Bacille Calmette-Guérin Vaccine Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Bacille Calmette-Guérin Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Bacille Calmette-Guérin Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Bacille Calmette-Guérin Vaccine Sales by Country (2018-2029)
3.6.3 Asia Pacific Bacille Calmette-Guérin Vaccine Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Bacille Calmette-Guérin Vaccine Market Facts & Figures by Country
3.7.1 Latin America Bacille Calmette-Guérin Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Bacille Calmette-Guérin Vaccine Sales by Country (2018-2029)
3.7.3 Latin America Bacille Calmette-Guérin Vaccine Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Bacille Calmette-Guérin Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Bacille Calmette-Guérin Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Bacille Calmette-Guérin Vaccine Sales by Country (2018-2029)
3.8.3 Middle East and Africa Bacille Calmette-Guérin Vaccine Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Bacille Calmette-Guérin Vaccine Sales by Type (2018-2029)
4.1.1 Global Bacille Calmette-Guérin Vaccine Sales by Type (2018-2023)
4.1.2 Global Bacille Calmette-Guérin Vaccine Sales by Type (2024-2029)
4.1.3 Global Bacille Calmette-Guérin Vaccine Sales Market Share by Type (2018-2029)
4.2 Global Bacille Calmette-Guérin Vaccine Revenue by Type (2018-2029)
4.2.1 Global Bacille Calmette-Guérin Vaccine Revenue by Type (2018-2023)
4.2.2 Global Bacille Calmette-Guérin Vaccine Revenue by Type (2024-2029)
4.2.3 Global Bacille Calmette-Guérin Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global Bacille Calmette-Guérin Vaccine Price by Type (2018-2029)
5 Segment by Application
5.1 Global Bacille Calmette-Guérin Vaccine Sales by Application (2018-2029)
5.1.1 Global Bacille Calmette-Guérin Vaccine Sales by Application (2018-2023)
5.1.2 Global Bacille Calmette-Guérin Vaccine Sales by Application (2024-2029)
5.1.3 Global Bacille Calmette-Guérin Vaccine Sales Market Share by Application (2018-2029)
5.2 Global Bacille Calmette-Guérin Vaccine Revenue by Application (2018-2029)
5.2.1 Global Bacille Calmette-Guérin Vaccine Revenue by Application (2018-2023)
5.2.2 Global Bacille Calmette-Guérin Vaccine Revenue by Application (2024-2029)
5.2.3 Global Bacille Calmette-Guérin Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global Bacille Calmette-Guérin Vaccine Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Bacille Calmette-Guérin Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Merck Bacille Calmette-Guérin Vaccine Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Sanofi Pasteur
6.2.1 Sanofi Pasteur Corporation Information
6.2.2 Sanofi Pasteur Description and Business Overview
6.2.3 Sanofi Pasteur Bacille Calmette-Guérin Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Sanofi Pasteur Bacille Calmette-Guérin Vaccine Product Portfolio
6.2.5 Sanofi Pasteur Recent Developments/Updates
6.3 Japan BCG Lab
6.3.1 Japan BCG Lab Corporation Information
6.3.2 Japan BCG Lab Description and Business Overview
6.3.3 Japan BCG Lab Bacille Calmette-Guérin Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Japan BCG Lab Bacille Calmette-Guérin Vaccine Product Portfolio
6.3.5 Japan BCG Lab Recent Developments/Updates
6.4 China National Biotec
6.4.1 China National Biotec Corporation Information
6.4.2 China National Biotec Description and Business Overview
6.4.3 China National Biotec Bacille Calmette-Guérin Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 China National Biotec Bacille Calmette-Guérin Vaccine Product Portfolio
6.4.5 China National Biotec Recent Developments/Updates
6.5 Serum Institute of India
6.5.1 Serum Institute of India Corporation Information
6.5.2 Serum Institute of India Description and Business Overview
6.5.3 Serum Institute of India Bacille Calmette-Guérin Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Serum Institute of India Bacille Calmette-Guérin Vaccine Product Portfolio
6.5.5 Serum Institute of India Recent Developments/Updates
6.6 GSBPL
6.6.1 GSBPL Corporation Information
6.6.2 GSBPL Description and Business Overview
6.6.3 GSBPL Bacille Calmette-Guérin Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.6.4 GSBPL Bacille Calmette-Guérin Vaccine Product Portfolio
6.6.5 GSBPL Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Bacille Calmette-Guérin Vaccine Industry Chain Analysis
7.2 Bacille Calmette-Guérin Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Bacille Calmette-Guérin Vaccine Production Mode & Process
7.4 Bacille Calmette-Guérin Vaccine Sales and Marketing
7.4.1 Bacille Calmette-Guérin Vaccine Sales Channels
7.4.2 Bacille Calmette-Guérin Vaccine Distributors
7.5 Bacille Calmette-Guérin Vaccine Customers
8 Bacille Calmette-Guérin Vaccine Market Dynamics
8.1 Bacille Calmette-Guérin Vaccine Industry Trends
8.2 Bacille Calmette-Guérin Vaccine Market Drivers
8.3 Bacille Calmette-Guérin Vaccine Market Challenges
8.4 Bacille Calmette-Guérin Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer